GIST is the most common subtype of STS and is characterized (in 85–90% of patients) by activating mutations in the receptor tyrosine kinases (RTKs) KIT and platelet-derived growth factor receptor (PDGFR) [7,8]. This evidence concerns the gene KIT and gastrointestinal stromal tumor.